Pieris Pharmaceuticals, Inc. PIRS
13.60 +13.60
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2023 · select a line to chart its full history
Income statement
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 42.81M | 25.90M | 31.42M | 29.32M | 46.28M | |
| 42.81M | 25.90M | 31.42M | 29.32M | 46.28M | |
| -29.76M | -43.47M | -51.83M | -33.92M | -27.16M | |
| -24.54M | -33.28M | -45.74M | -37.23M | -25.47M | |
| -21.60 | -36.00 | -56.80 | -54.40 | -44.80 |
Balance sheet
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 17.40M | 38.63M | 117.76M | 70.44M | 62.26M | |
| 38.68M | 95.49M | 153.56M | 105.01M | 141.10M | |
| 11.92M | 67.56M | 102.81M | 73.98M | 89.75M | |
| 26.76M | 27.93M | 50.76M | 31.03M | 51.35M |
Cash flow
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| -53.82M | -59.93M | -7.66M | -45.90M | -52.47M | |
| 12.00M | -21.24M | -949.00K | 39.21M | 9.84M | |
| 19.80M | 7.21M | 59.13M | 10.12M | 32.17M | |
| -171.00K | -1.04M | -949.00K | -2.73M | -2.46M | |
| -21.24M | -79.13M | 47.33M | 8.18M | -12.61M |